146
Views
43
CrossRef citations to date
0
Altmetric
Original Research

Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells

, , , , , , & show all
Pages 3353-3365 | Published online: 07 Jun 2018

References

  • WeiXXPerryJChangEClinical variables associated with overall survival in metastatic castration-resistant prostate cancer patients treated with sipuleucel-t immunotherapyClin Genitourin Cancer Epub20171227
  • VerboogenDRDingjanIReveloNHVisserLJter BeestMvan den BogaartGThe dendritic cell side of the immunological synapseBiomol Concepts201671172826741354
  • HanJAKangYJShinCFerritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine developmentNanomedicine201410356156924262997
  • MouYHouYChenBIn vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxideInt J Nanomedicine201162633264022114494
  • CintoloJADattaJMathewSJCzernieckiBJDendritic cell-based vaccines: barriers and opportunitiesFuture Oncol20128101273129923130928
  • MouYChenBZhangYInfluence of synthetic superpara-magnetic iron oxide on dendritic cellsInt J Nanomedicine201161779178621980240
  • ChenHMWangPHChenSSShikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccineCancer Immunol Immunother201261111989200222527248
  • PaulisLEMandalSKreutzMFigdorCGDendritic cell-based nano-vaccines for cancer immunotherapyCurr Opin Immunol201325338939523571027
  • ModyNDubeySSharmaRAgrawalUVyasSPDendritic cell-based vaccine research against cancerExpert Rev Clin Immunol201511221323225467734
  • Romero MendezIZShiYHogenEschHHemSLPotentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvantsVaccine200725582583317014935
  • MannhalterJWNeychevHOZlabingerGJAhmadREiblMMModulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentationClin Exp Immunol19856111431513876178
  • O’HaganDTMacKichanMLSinghMRecent developments in adjuvants for vaccines against infectious diseasesBiomol Eng2001183698511566599
  • LuFBoutselisIBorchRFHogeneschHControl of antigen-binding to aluminum adjuvants and the immune response with a novel phosphonate linkerVaccine201331404362436723887038
  • RhieGEParkYMHanJSYuJYSeongWKOhHBEfficacy of non-toxic deletion mutants of protective antigen from Bacillus anthracisFEMS Immunol Med Microbiol200545234134716019195
  • UsingerWRA comparison of antibody responses to veterinary vaccine antigens potentiated by different adjuvantsVaccine19971517–18190219079413100
  • LiXAldayelAMCuiZAluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticlesJ Control Release201417314815724188959
  • CuiXBeloSKrugerDAluminium hydroxide stabilised MnFe2O4 and Fe3O4 nanoparticles as dual-modality contrasts agent for MRI and PET imagingBiomaterials201435225840584624768194
  • HePZouYHuZAdvances in aluminum hydroxide-based adjuvant research and its mechanismHum Vaccin Immunother201511247748825692535
  • BeckerLCBoyerIBergfeldWFSafety assessment of alumina and aluminum hydroxide as used in cosmeticsInt J Toxicol2016353 Suppl16s33s27913785
  • ThomasTJTajmir-RiahiHAThomasTPolyamine-DNA interactions and development of gene delivery vehiclesAmino Acids201648102423243127168074
  • AnselmoACMitragotriSA review of clinical translation of inorganic nanoparticlesAAPS J20151751041105425956384
  • ZhaoJPanNHuangFVx3-functionalized alumina nanoparticles assisted enrichment of ubiquitinated proteins from cancer cells for enhanced cancer immunotherapyBioconjug Chem201829378679429382195
  • LiYHWangLXPangPYTumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacyClin Cancer Res201117227047705722068657
  • SuHLuoQXieHTherapeutic antitumor efficacy of tumor-derived autophagosome (DRibble) vaccine on head and neck cancerInt J Nanomed20151019211930
  • LiHYLiYHJiaoJHuHMAlpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour responseNat Nanotechnol201161064565021926980
  • Fuertes MarracoSAGrosjeanFDuvalANovel murine dendritic cell lines: a powerful auxiliary tool for dendritic cell researchFront Immunol2012333123162549
  • van de VenRReursAWWijnandsPGExposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapyCancer Immunol Immunother201261218119121874304
  • WangSTianYTianWSelectively sensitizing malignant cells to photothermal therapy using a CD44-targeting heat shock protein 72 depletion nanosystemACS Nano20161098578859027576159
  • MayorekNNaftali-ShaniNGrunewaldMDiclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activityPLoS One201059e1271520856806
  • RoszkowskiJJYuDCRubinsteinMPMcKeeMDColeDJNishimuraMICD8-independent tumor cell recognition is a property of the T cell receptor and not the T cellJ Immunol200317052582258912594285
  • MouYXingYRenHThe effect of superparamagnetic iron oxide nanoparticle surface charge on antigen cross-presentationNanoscale Res Lett20171215228102523
  • RenHZhaoSLiWTherapeutic antitumor efficacy of B cells loaded with tumor-derived autophagasomes vaccine (DRibbles)J Immunother201437838339325198526
  • WinSJWardVKDunbarPRYoungSLBairdMACross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathwayImmunol Cell Biol201189668168821221122
  • LiXChenYWangMMaYXiaWGuHA mesoporous silica nanoparticle – PEI – fusogenic peptide system for siRNA delivery in cancer therapyBiomaterials20133441391140123164421
  • WangGDTanYZWangHJZhouPAutophagy promotes degradation of polyethyleneimine-alginate nanoparticles in endothelial progenitor cellsInt J Nanomedicine2017126661667528924349
  • MellmanISteinmanRMDendritic cells: specialized and regulated antigen processing machinesCell2001106325525811509172
  • VogtASieversELukacs-KornekVImproving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivoLiver Int201434344746123998316
  • JiangHZhangYYinXConstruction and evaluation of rats’ tolerogenic dendritic cells (DC) induced by NF-κB decoy methodAfr Health Sci201414362663325352881
  • AmigorenaSSavinaAIntracellular mechanisms of antigen cross presentation in dendritic cellsCurr Opin Immunol201022110911720171863
  • YeWXingYPaustianCCross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cellsJ Transl Med20141210024735498
  • SuSZhouHXueMAnti-tumor efficacy of a hepatocellular carcinoma vaccine based on dendritic cells combined with tumor-derived autophagosomes in murine modelsAsian Pac J Cancer Prev20131453109311623803088
  • AngelLPDivinoCMBrowerSTChenSHA novel immunocytolytic factor secreted by pancreatic adenocarcinomaJ Surg Res200091215415810839965